Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 15, 2015
Sarah Spinler, PharmD, professor of clinical pharmacy at the Philadelphia College of Pharmacy, explains why some patients with atrial fibrillation should be prescribed a new oral anticoagulant (NOAC) instead of warfarin.